344 results on '"Uro-Coste, Emmanuelle"'
Search Results
2. CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas
3. PLAG1 fusions extend the spectrum of PLAG(L)-altered CNS tumors
4. Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status
5. CNS neuroblastoma, FOXR2-activated and its mimics: a relevant panel approach for work-up and accurate diagnosis of this rare neoplasm
6. CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult population
7. Clinico-pathological and epigenetic heterogeneity of diffuse gliomas with FGFR3::TACC3 fusion
8. Beneath HMGA2 alterations in pleomorphic adenomas: Pathological, immunohistochemical, and molecular insights
9. Pediatric spinal pilocytic astrocytomas form a distinct epigenetic subclass from pilocytic astrocytomas of other locations and diffuse leptomeningeal glioneuronal tumours
10. Muscular phenotype description of abnormal THOC2 splicing
11. Clinicopathological and molecular characterization of three cases classified by DNA-methylation profiling as “Glioneuronal Tumors, NOS, Subtype A”
12. Survival outcomes, prognostic factors, and effect of adjuvant radiotherapy and prophylactic neck dissection in salivary acinic cell carcinoma: A prospective multicenter REFCOR study of 187 patients
13. A novel YAP1-MAML2 fusion in an adult supra-tentorial ependymoma, YAP1-fused
14. Natural Course and Prognosis of Primary Spinal Glioblastoma: A Nationwide Study
15. Disseminated diffuse midline gliomas, H3K27-altered mimicking diffuse leptomeningeal glioneuronal tumors: a diagnostical challenge!
16. PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum
17. Mucoepidermoid carcinoma of salivary glands: A French Network of Rare Head and Neck Tumors (REFCOR) prospective study of 292 cases
18. Evaluating next-generation sequencing in neuromuscular diseases with neonatal respiratory distress
19. Contribution of narrow band imaging in delineation of laryngopharyngeal superficial cancer spread: a prospective study
20. A recurrent RYR1 mutation associated with early-onset hypotonia and benign disease course
21. The molecular landscape of ETMR at diagnosis and relapse
22. Paraneoplastic neuromyelitis optica and ovarian teratoma: A case series
23. Randomized phase III trial of metabolic imaging-guided dose escalation of radio-chemotherapy in patients with newly diagnosed glioblastoma (SPECTRO GLIO trial).
24. 849: Relapse Risk stratification in pediatric ependymoma patients using clinical data and radiomics
25. Two novel tumours with NTRK2 fusion in the methylation class of extraventricular neurocytomas, including one intraventricular.
26. Definitive radiochemotherapy or initial surgery for oropharyngeal cancer: To what extent can p16 expression be used in the decision process?
27. The EP300:BCOR fusion extends the genetic alteration spectrum defining the new tumoral entity of “CNS tumors with BCOR internal tandem duplication”
28. Brain tumor with an ATXN1-NUTM1 fusion gene expands the histologic spectrum of NUTM1-rearranged neoplasia
29. ETMR-like infantile cerebellar embryonal tumors in the extended morphologic spectrum of DICER1-related tumors
30. Molecular Profiling of Salivary Gland Intraductal Carcinoma Revealed a Subset of Tumors Harboring NCOA4-RET and Novel TRIM27-RET Fusions: A Report of 17 cases
31. Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging
32. Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort
33. HPV-related Multiphenotypic Sinonasal Carcinoma: An Expanded Series of 49 Cases of the Tumor Formerly Known as HPV-related Carcinoma With Adenoid Cystic Carcinoma-like Features
34. A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted Oligodendrogliomas.
35. Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome
36. Tumor cells with neuronal intermediate progenitor features define a subgroup of 1p/19q co‐deleted anaplastic gliomas
37. ETV4 immunohistostaining is a sensitive and specific diagnostic biomarker for CIC‐rearranged sarcoma of the central nervous system.
38. Therapeutic use of CCR5 antagonists is supported by strong expression of CCR5 on CD8+ T cells in progressive multifocal leukoencephalopathy-associated immune reconstitution inflammatory syndrome
39. Prognostic Relevance of Histomolecular Classification of Diffuse Adult High-Grade Gliomas with Necrosis
40. A comparative immunohistochemistry study of diagnostic tools in salivary gland tumors: usefulness of mammaglobin, gross cystic disease fluid protein 15, and p63 cytoplasmic staining for the diagnosis of mammary analog secretory carcinoma?
41. Evidence for BRAF V600E and H3F3A K27M double mutations in paediatric glial and glioneuronal tumours
42. Is neuroendocrine differentiation useful to discriminate primary sinonasal intestinal-type adenocarcinomas from metastatic colorectal adenocarcinomas?
43. Radiotherapy‐PCV versus radiotherapy‐temozolomide for IDH ‐mutant anaplastic astrocytoma: a retrospective multicentre analysis of the French POLA cohort
44. Rosette‐forming glioneuronal tumours are midline, FGFR1‐mutated tumours.
45. Mast cell transcripts are increased within and outside multiple sclerosis lesions
46. Recessive TTN truncating mutations define novel forms of core myopathy with heart disease
47. Longitudinal Analysis of Gene Expression in Porcine Skeletal Muscle After Post-Injection Local Injury
48. NCOA4-RET and TRIM27-RET are Characteristic Gene Fusions in Salivary Intraductal Carcinoma, Including Invasive and Metastatic Tumors: Is 'Intraductal' Correct?
49. Low‐grade epilepsy‐associated neuroepithelial tumours with a prominent oligodendroglioma‐like component: The diagnostic challenges.
50. An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB‐fused broadening the spectrum of tumor entities in comparison with their soft tissue counterparts.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.